Gujaral told CNBC-TV18, "Aurobindo Pharma will not give trading moves, it will probably move once in a while. So probably investment stoploss would be Rs 470. A trading stoploss is around Rs 580. Once we can get pass Rs 665, that should be next level, one should be looking at, one should easily get to Rs 750."
He further added, "Pharma stocks generally move when things in the market seem uncertain, they are not great growth stocks. So in an environment like this, one will find pharma generally moving sideways but in a software market one will often find pharma outperforming. So that's what investors need to keep in mind."
Disclosure: We have long positions on the Nifty and we may have discussed some of these stocks with our clients.
